← Leaderboards
George F Muschler
Cleveland Clinic Foundation
$11,607,021
Attributed
$11,607,021
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$11,582,021 · 7
AHRQ$25,000 · 1
By mechanism
R01$11,199,625 · 5
R21$365,396 · 1
R13$42,000 · 2
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Foundation
Same institution · by research overlap
- Ronald Joseph Midura$2,024,816
Others in their field
Top investigators on “Bone Marrow”
- Charles A Coltman · Southwest Oncology Group$141,983,231
- Mary M Horowitz · Medical College Of Wisconsin$136,789,389
- David Heimbrook · Leidos Biomedical Research, Inc.$56,049,457
- Richard L Schilsky · University Of Chicago$50,043,295
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$48,148,202
- J. Mark Cline · Wake Forest University$31,844,583
Research focus
Bone MarrowStem CellsConnective TissueFuturePerformanceBoneSurfaceInsightProgenitorTissuesBiologicalCellsImageIn VitroCartilageIn VivoSourceBaseJointsTissue EngineeringImage AnalysisFatty Acid Glycerol EstersResourcesCommunities
Grant awards (26)
Understanding and Using Variation in Source Materials for MSC Fabrication$630,435
R01 · FY2023 · DE · contact PI
Understanding and Using Variation in Source Materials for MSC Fabrication$572,696
R01 · FY2022 · DE · contact PI
Understanding and Using Variation in Source Materials for MSC Fabrication$559,242
R01 · FY2021 · DE · contact PI
Understanding and Using Variation in Source Materials for MSC Fabrication$622,650
R01 · FY2020 · DE · contact PI
Understanding and Using Variation in Source Materials for MSC Fabrication$669,868
R01 · FY2019 · DE · contact PI
The Epidemiology of Human Chondrogenic Progenitor Cells$652,842
R01 · FY2016 · AR · contact PI
The Epidemiology of Human Chondrogenic Progenitor Cells$636,516
R01 · FY2015 · AR · contact PI
Early Identification and Characterization of Connective Tissue Progenitors$165,263
R21 · FY2015 · AR · contact PI
The Epidemiology of Human Chondrogenic Progenitor Cells$632,073
R01 · FY2014 · AR · contact PI
Early Identification and Characterization of Connective Tissue Progenitors$200,133
R21 · FY2014 · AR · contact PI
The Epidemiology of Human Chondrogenic Progenitor Cells$575,648
R01 · FY2013 · AR · contact PI
Extended Learning Curriculum for the Cleveland Clinic Orthopaedic & Rheumatology$25,000
R13 · FY2009 · HS · contact PI
Cleveland Clinic Orthopaedic and Rheumatology Care -- Quality Innovation Summit 2$17,000
R13 · FY2009 · AR · contact PI
Optimizing Assays of Human Stem Cells in Bone Marrow$362,679
R01 · FY2007 · AG · contact PI
Epidemiology of Connective Tissue Progenitor Populations$419,980
R01 · FY2006 · AR · contact PI
Optimizing Assays of Human Stem Cells in Bone Marrow$373,511
R01 · FY2006 · AG · contact PI
Epidemiology of Connective Tissue Progenitor Populations$419,933
R01 · FY2005 · AR
Optimizing Assays of Human Stem Cells in Bone Marrow$382,500
R01 · FY2005 · AG
OPTIMIZING BONE MARROW AS A BONE GRAFT$321,194
R01 · FY2005 · AR
OPTIMIZING BONE MARROW AS A BONE GRAFT$523,330
R01 · FY2004 · AR
Epidemiology of Connective Tissue Progenitor Populations$445,629
R01 · FY2004 · AR
Optimizing Assays of Human Stem Cells in Bone Marrow$370,416
R01 · FY2004 · AG
OPTIMIZING BONE MARROW AS A BONE GRAFT$539,065
R01 · FY2003 · AR
Epidemiology of Connective Tissue Progenitor Populations$435,228
R01 · FY2003 · AR
OPTIMIZING BONE MARROW AS A BONE GRAFT$569,779
R01 · FY2002 · AR
Epidemiology of Connective Tissue Progenitor Populations$484,411
R01 · FY2002 · AR